Overview of Meted

Property	Description
Active Ingredients	Sodium Salicylate and Sulfur
Form	Topical preparations (shampoo, cream, bar, lotion)
Pharmacological Class	Miscellaneous Topical Agent; Keratolytic/Antifungal Combination
General Purpose	Skin normalizer and cleanser
Route	Topical route

Meted: Definition and Pharmacological Classification

Meted is a non-prescription combination product strictly intended for external application via the topical route. Pharmacologically, the preparation is classified as a Miscellaneous Topical Agent, specifically utilized for its Keratolytic/Antifungal Combination properties. This classification is clinically recognized, reflecting the product's design to manage skin conditions characterized by scaling and excess sebum. The preparation is versatile, supplied across various topical preparations—including shampoos, creams, and cleansing bars—to target specific anatomical areas like the scalp or body skin.

Composition and Origin: Is Meted Natural or Synthetic?

The formulation relies upon the dual activity of Sodium Salicylate and elemental Sulfur. The Sodium Salicylate component, which acts as the primary keratolytic agent, is typically a synthetically derived salt form of Salicylic Acid. In contrast, Sulfur is an elemental mineral and is an accepted active ingredient in topical preparations. This ingredient combination is a distinguishing feature, reflecting the complementary relationship between the keratolytic action and the mild antiseptic property. The components are suspended in a specialized base/vehicle, engineered to maintain stability and ensure efficient delivery.

General Purpose: How the Dual Action Benefits the Skin

The general, verifiable purpose of Meted is to act as an effective skin normalizer and cleanser. Its benefit stems from its dual action capability, which is a known strategy in dermatology. The Salicylate-derived component provides the necessary keratolytic action, helping to loosen and facilitate the removal of accumulated outer skin cells. Simultaneously, the Sulfur component contributes a mild regulating effect by helping to control surface oil and provides an antiseptic-like function. This comprehensive effort is broadly intended to relieve the symptoms associated with excessive skin scaling, follicular plugging, and surface congestion.

Regulatory References

NIH DailyMed Classification

What side effects are possible with Meted?

Possible Side Effects and Safety Information

Adverse Reaction Scope

The official safety profile for this topical combination is structured around a clear distinction between common local effects and rare systemic concerns. Adverse reactions primarily involve the Skin and Subcutaneous Tissue Disorders and, rarely, the Immune System Disorders.

Category	Description
Common/Expected Reactions	Local effects such as skin irritation (if not present before use), unusual dryness of the skin, redness (erythema), peeling (scaling) of the skin, and stinging or burning sensations.
Serious Adverse Reactions	Rare, serious, and potentially life-threatening allergic reactions (hypersensitivity) are documented. Symptoms may include throat tightness, difficulty breathing, feeling faint, or swelling of the eyes, face, lips, or tongue.

Population-Specific Safety Considerations

Specific constraints are noted in regulatory documents, mainly concerning the risk of systemic absorption of the salicylate component:

Pediatric Use: Safety and effectiveness are not established in children under 12 years of age. Young children may be at increased risk of unwanted systemic effects due to greater absorption through the skin. Use is contraindicated in children or teenagers with influenza (flu) or varicella (chicken pox) due to the risk of Reye's syndrome.
Other Constraints: Caution is advised for patients with diabetes or poor circulation, or those with kidney or liver disease, especially with prolonged or widespread use.

Safety Restrictions and Patterns

The product is contraindicated in persons with a known hypersensitivity or allergy to any of its components. Symptoms of serious hypersensitivity may occur within minutes to a day or longer after product use. Use on inflamed, irritated, or infected skin areas may cause severe local irritation. Concomitant use with other peeling preparations may lead to severe irritation.

Overdose and Emergency Response

The official overdose profile for topical preparations containing Sodium Salicylate and Sulfur primarily centers on the systemic absorption of the salicylate component. Overdose, which may result from excessive topical application, use on large or compromised skin areas, or accidental ingestion, is characterized by a condition known as salicylism. Documented manifestations include symptoms such as tinnitus, dizziness, confusion, nausea, and vomiting, reflecting potential Central Nervous System (CNS) effects. Severe systemic toxicity can lead to metabolic derangements, including metabolic acidosis, and can progress to seizures.

Immediate medical attention is officially required for any signs of systemic toxicity or the sudden onset of severe, potentially life-threatening hypersensitivity reactions. These reactions, which include throat tightness, difficulty breathing, and swelling of the face or tongue, are specific triggers for seeking urgent care. Patients should also contact a Poison Control Center for suspected exposure.

In cases of toxicity, the standard regulatory approach involves symptomatic and supportive treatment, as no specific antidote is known. Procedures include hospital evaluation and continuous monitoring for symptomatic patients. Furthermore, regulatory documents specify that young children are at increased risk of systemic absorption, and a risk of chronic toxicity is noted with repeated supratherapeutic application in vulnerable populations, such as the elderly.

Therapeutic Uses of Meted

What Meted Treats: Main Uses and Benefits

Meted is a topical agent that is generally used to provide supportive relief and assists with maintaining functional stability across several common dermatological domains. As an example of its therapeutic focus, the combination of sulfur and a salicylate-derived ingredient is commonly used for managing flaking and scaling associated with dandruff and seborrheic dermatitis. Its benefit lies in helping patients cope more steadily with chronic and recurrent skin manifestations by easing the overall symptom load.

The preparation is considered relevant in contexts involving increased discomfort, as it helps address symptom clusters related to superficial fungal overgrowth, such as Tinea versicolor. It is also applied in scenarios where additional management of discomfort is required for issues like excess surface oil (sebum) and follicular plugging in cases of mild to moderate acne vulgaris.

The primary therapeutic benefit is often summarized as supportive care: “The aim of using this product is to help ease the overall symptom burden and contribute to easing distress during symptomatic periods.”

Quick Fact: Relief for Persistent Skin Symptoms

Meted is commonly used across conditions presenting with episodic manifestations, relevant for the symptomatic management of three key areas: seborrheic dermatitis, dandruff (Pityriasis capitis), and mild to moderate acne vulgaris. It is also relevant for managing symptoms of Tinea versicolor. In all these scenarios, it supports patients during difficult episodes by easing distress and helping manage symptoms that interfere with daily comfort.

Eligibility and Restrictions for Use

Who Can and Cannot Use Meted? Official Regulatory Information

Official regulatory documents define the population eligibility for Meted (Sodium Salicylate and Sulfur topical) based on absolute prohibitions and conditional use constraints.

Populations Not Eligible for Use

The medicine is contraindicated for individuals with a known or suspected hypersensitivity to any of its components, including Sodium Salicylate, Sulfur, or any excipients.

Meted must not be applied to broken skin, inflamed areas, or denuded skin due to the potential for increased systemic absorption of the salicylate component.

Age and Physiological Constraints

Category	Regulatory Status or Constraint
Adults and Older Adults	Permitted for use under standard labeled conditions.
Infants and Young Children	Use requires caution due to increased risk of systemic absorption of the salicylate.
Pregnancy and Lactation	Use is conditional; safety is not definitively established, and caution is required, as excretion into human milk is unknown.

Eligibility is not defined by specific comorbidity restrictions like renal or hepatic impairment in the product's official labeling, but is strictly determined by hypersensitivity and local skin condition.

What should I know about interactions with other medicines?

Local and Topical Interaction Restrictions

The interaction profile for Meted (Sodium Salicylate/Sulfur topical) is governed by strict regulatory constraints regarding co-administration. Combining the product with Topical Mercury-Containing Preparations (such as Ammoniated Mercury Ointment) is formally prohibited due to a documented chemical reaction with the sulfur component, which results in skin irritation and black staining. Co-administration with Other Topical Peeling Agents or Acne Preparations (e.g., Benzoyl Peroxide or Tretinoin) is restricted due to the potential for pharmacodynamic reinforcement, leading to severe and unusual skin irritation. This requires a mandatory separation in time or location of application.

Systemic Exposure and Drug Clearance

Regulatory warnings describe potential systemic interactions stemming from the absorbed salicylate component. Co-administration with Oral Anticoagulants is noted to increase the documented risk of bleeding. The salicylate component may also decrease the clearance of Methotrexate, which is described as increasing the risk of Methotrexate clinical toxicity.

Population-Specific Interaction Notes

Specific populations face documented restrictions. Meted is strictly contraindicated in children or teenagers with Varicella or Influenza due to the regulatory warning concerning the potential for developing Reye's syndrome. Additionally, patients with documented significant renal or hepatic impairment are noted to be at increased risk of systemic salicylate accumulation.

Mechanism of Action

Meted is a targeted inhibitor that selectively accumulates within the bone matrix. Following administration, the drug exhibits high binding affinity for the hydroxyapatite crystal, which concentrates the compound specifically at sites of high bone turnover. This allows for the focused engagement of its biological target. Meted works at the cellular level by disrupting the function of osteoclasts, the cells responsible for dissolving bone tissue. It achieves this by the direct inhibition of the V0 domain proton pump, a critical enzyme complex. This inhibition prevents the necessary acidification of the resorption lacunae, thereby paralyzing the osteoclast's resorptive action. This molecular event effectively decreases the overall rate of bone resorption, reducing the release of bone minerals from the matrix and modulating the physiological balance between bone formation and resorption.

Dosage and Administration Information

How Meted is Used: Official Administration Guidelines

Meted is a dermatological preparation used according to specific instructions to ensure proper application and efficacy.

Administration Scope

Instruction	Details
Route of administration	Topical use on the skin and scalp only.
Dosing schedule	Apply a sufficient amount to produce an abundant lather on the affected area.
Age-group administration rules	Dosing for children and older adults follows the same application rules as for adults.
Special procedural conditions	The product is strictly for external use only and must not be taken orally.

Frequency and Procedure

Meted is typically used following a defined schedule and application protocol to manage scaling and associated symptoms. The frequency may range from at least twice a week up to use every time the hair is shampooed for maximum control.

Liquid forms, such as the shampoo, are instructed to be shaken well before use to ensure proper content mixing.

Official step sequence:

The hair and affected skin must be thoroughly wetted prior to application.
The product is applied, worked into a full lather, and rinsed off.
The application process is then repeated (lathering again), and the lather is then rinsed fully and thoroughly from the area.

Connection to the overall use protocol:

This structured use protocol establishes the preparation as a topical treatment with a mandated two-step wash cycle and clear frequency parameters. The instructions standardize both the required quantity—enough to create a lather—and the necessity of a repeated wash sequence to optimize ingredient contact. Adherence to a regular use pattern is emphasized to manage the target conditions.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Meted

Evidence for Managing Seborrheic Dermatitis and Dandruff

Studies were conducted examining the Sodium Salicylate and Sulfur combination for scaling and flaking associated with mild to moderate seborrheic dermatitis and dandruff. These investigations primarily utilized Randomized Controlled Trials (RCTs) and comparative studies, which were used in research exploring how symptoms change over time in adult and adolescent populations. The outcomes related to physical discomfort were a key focus, with studies examining tools to measure the degree of scaling on the scalp and patient-reported outcomes describing perceived discomfort, such as itch severity. Research describes changes measured during the study period over defined short-term to medium-term intervals. Comparative evidence is lacking for direct comparison against all newer prescription antifungal agents.

Evidence for Use in Mild to Moderate Acne Vulgaris

Studies were conducted examining short-term symptom changes related to mild to moderate acne vulgaris. The research examined the use of the combination in adolescents and young adults, focusing on outcomes linked to inflammatory or irritative states and follicular plugging. Studies monitored the change in lesion counts, differentiating between inflammatory spots and non-inflammatory lesions. Data show patterns related to the effect on surface oil and congestion, which were outcomes measured in the studies. However, evidence quality varies across studies, and many older trials carry a high risk of bias, as noted in systematic reviews.

Research Gaps and Unanswered Questions

While the therapeutic classes of the product's active ingredients are well-established, sample sizes were modest in many of the specific combination trials. Long-term effects are not fully established, as follow-up durations were limited in many of the core studies. Findings were mixed in some comparative trials, meaning that a clear picture of its relative standing against all new topical treatments is not consistently available across the literature. Research highlights what is known — and what is still uncertain, making clear that more contemporary and large-scale comparative research would contribute to the broader evidence landscape.

Key Studies & References

Frequently Asked Questions (FAQ)

Common questions about Meted (FAQ)

Q: Is Meted the same kind of drug as other common medications for this condition?

A: According to official sources, Meted is classified as a combination product. It contains both a keratolytic agent, which helps the skin shed dead cells, and an antibacterial/antifungal agent. This dual-action approach is a key feature noted in its use for conditions like acne and seborrheic dermatitis.

Q: Is Meted a treatment that is taken for a short time or long-term?

A: Regulatory information addresses safety considerations for long-term therapy with this topical product. Official safety data indicates that continuous or prolonged use requires careful monitoring for signs of potential local irritation or sensitization.

Q: Are there any common side effects of Meted that usually go away after a few days?

A: Official information indicates that some common local effects, such as mild skin irritation or a stinging sensation, are expected when first starting the product. These initial effects may lessen or resolve as the body adjusts to the medication over time.

Q: What is the official classification for Meted's use in children?

A: Official labeling states that the safety and effectiveness of this product have not been established in children under 12 years of age. It is also important to note that the product is strictly contraindicated in children or teenagers who have influenza (the flu) or chickenpox due to the regulatory warning regarding the risk of Reye's syndrome.

Q: Does Meted need to be taken at a specific time of day for it to work correctly?

A: Official dosing guidelines focus on the required frequency of application, such as once or twice daily or as determined by a healthcare provider. The regulatory information does not mandate that the product must be applied at a specific time of day for it to be effective.

Q: Can Meted cause sensitivity to the sun or skin reactions?

A: The official safety profile for the product lists common local reactions like redness and skin irritation. Some components of the drug class, such as salicylates, have been associated with sensitivity to light (photosensitivity).

Q: What are the criteria used by official bodies for classifying Meted's safety?

A: Official bodies use various systems to classify drug safety. For pregnancy, this product is categorized as Pregnancy Category C. This classification is used when animal reproduction studies have not been conducted, and it signifies that use is conditional, requiring a cautious evaluation.

Q: Does Meted contain any ingredients that are known allergens?

A: Official documentation strongly contraindicates use for anyone with a known hypersensitivity to any of its components, including both active and inactive ingredients. The product's composition is noted to include common excipients like parabens (methyl paraben, propyl paraben), which are known to cause allergic reactions in some susceptible individuals.

Q: How does Meted differ from the generic version of the medicine?

A: Regulatory guidance indicates that the active ingredients in the brand name product and the generic equivalent must be the same to ensure bioequivalence. The primary differences between the two versions are usually found in the inactive ingredients (excipients), the physical appearance of the product, or the cost.

Q: What is the expected timeline for Meted to start having an effect?

A: Official clinical information suggests that the full benefit may be observed over a defined period of treatment, which may take several weeks or longer. Noticeable changes are expected to occur gradually during this course of consistent use.

Q: How long after starting Meted can I expect to see the full benefit?

A: Clinical information suggests that the timeframe for observing the full therapeutic effect can be up to 12 weeks of consistent use. The exact time may vary based on the individual person and the specific skin condition being treated.

Q: Does Meted cause weight gain or weight loss?

A: Weight changes (gain or loss) are not listed among the common local or systemic adverse reactions in the official regulatory documentation for this topical product.

Q: Can Meted affect my sleep patterns or cause insomnia?

A: Official regulatory documentation does not list insomnia or other sleep pattern disturbances among the commonly reported adverse reactions for this topical product.

Q: Is it typical to feel fatigued when first taking Meted?

A: Fatigue is not listed among the commonly reported local or systemic adverse reactions in the official regulatory documentation for this topical product.

Q: What kinds of food or drink are known to interact with Meted?

A: Regulatory information does not list any specific known food or drink interactions for the topical use of this product.

Q: Is it safe to consume alcohol while taking a course of Meted?

A: While there is no specific alcohol contraindication for the topical product, official warnings related to the salicylate component advise caution. This is due to the potential for increased gastrointestinal toxicity risk if salicylates are absorbed systemically in individuals with a history of alcoholism.

Q: Is Meted considered a habit-forming or addictive drug?

A: The product is not classified as a controlled substance under regulatory guidelines. Therefore, it is not listed in official documentation as having an abuse or addiction potential.

Q: What should I do if I accidentally miss a dose of Meted?

A: If a dose is missed, official regulatory sources advise applying it as soon as it is remembered. However, if it is almost time for the next application, it is recommended to skip the missed dose and continue with the regular schedule. Regulatory guidance states that extra product should not be used to compensate for a missed dose.

Q: Is it normal to feel a mild headache when first taking Meted?

A: Headache is not listed among the commonly reported local or systemic adverse reactions in the official regulatory documentation for this product.

Q: Does Meted affect my ability to drive or operate machinery?

A: The official warnings for the topical product do not list common central nervous system effects such as drowsiness or dizziness. As such, official regulatory labeling typically does not include specific restrictions regarding driving or operating machinery.

Q: Are there official descriptions of how Meted might affect mood or mental state?

A: Mood changes are not listed as a common side effect of normal topical use. However, regulatory sources note that symptoms associated with high systemic absorption or salicylate toxicity can potentially include effects on the central nervous system, such as confusion or psychic disturbances, though this is related to toxicity, not normal use.

Q: How long does Meted stay in the body after the last dose is taken?

A: Clinical pharmacology information addresses the clearance rate of the active ingredients. The biological half-life of one of the ingredients when taken orally is noted to be between 7 and 12.8 hours, though absorption through intact skin from the topical product is typically considered low.

Q: Are there certain activities or sports that should be limited while using Meted?

A: Regulatory documentation does not specify restrictions on participation in general activities or sports while using this topical product. Official warnings are typically reserved for interactions with other medications or specific medical conditions.

Q: What is the risk of accidental overdose with Meted as described in product information?

A: Regulatory documents indicate that an overdose of the topical product is not generally associated with dangerous outcomes when used externally. However, if the medication is accidentally swallowed, official guidance directs that emergency medical attention should be sought immediately.

Q: What does the patient information leaflet say about feeling dizzy on Meted?

A: Dizziness is not listed among the commonly reported side effects of normal topical use. However, it is a documented symptom associated with salicylate toxicity, which is a risk that may occur with excessive systemic absorption.

How should Meted be stored and disposed of?

Official Storage and Disposal Requirements

Regulatory documents define specific conditions to maintain the stability and safety of Meted. Storage must adhere strictly to the temperature range specified on the label, and the medicine must be protected from light and moisture if required.

Storage Conditions

Requirement	Description
Temperature	Store at the labeled temperature (e.g., controlled room temperature).
Protection	Keep the product in its original, tightly closed container.
Handling	Do not freeze or expose the product to temperatures exceeding the maximum stated limit.

Disposal Rules

All medicines must be stored out of the sight and reach of children. Disposal of unused or expired Meted should follow official regulatory guidance. The preferred method is using an authorized drug take-back program. If a program is unavailable, follow specific government instructions for household disposal; do not flush the medicine down the sink or toilet unless explicitly instructed to do so by a regulatory agency.

Meted